Found: 10
Select item for more details and to access through your institution.
Antibiotic Susceptibility of Serratia marcescens and Serratia liquefaciens.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 315, doi. 10.1159/000007304
- By:
- Publication type:
- Article
Comparative in vitro Activity of Older and Newer Fluoroquinolones against Respiratory Tract Pathogens.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 309, doi. 10.1159/000007303
- By:
- Publication type:
- Article
Potential Salvage Therapy for Accidental Intrathecal Vincristine Administration: A Preliminary Experimental Study.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 322, doi. 10.1159/000007305
- By:
- Publication type:
- Article
Safety and Efficacy of Cefpirome in Comparison with Ceftazidime in Chinese Patients with Sepsis due to Bacterial Infections.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 371, doi. 10.1159/000007311
- By:
- Publication type:
- Article
Prediction of Flucytosine-Induced Thrombocytopenia Using Creatinine Clearance.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 335, doi. 10.1159/000007307
- By:
- Publication type:
- Article
In vitro Comparative Dynamics of Modified-Release Clarithromycin and of Azithromycin.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 342, doi. 10.1159/000007308
- By:
- Publication type:
- Article
Perioperative Infection Prophylaxis and Risk Factor Impact in Colon Surgery.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 353, doi. 10.1159/000007309
- By:
- Publication type:
- Article
Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 364, doi. 10.1159/000007310
- By:
- Publication type:
- Article
Taxol Resistance.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 327, doi. 10.1159/000007306
- By:
- Publication type:
- Article
Time-Kill Studies of Antimicrobial Combinations Including Cefotaxime, Ceftriaxone, Vancomycin and Meropenem against Cephalosporin-Resistant Streptococcus pneumoniae.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 303, doi. 10.1159/000007302
- By:
- Publication type:
- Article